SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030437588> ?p ?o ?g. }

Showing items 1 to 100 of ±217 with 100 items per page.

W2030437588 endingPage "62" @default.
W2030437588 startingPage "53" @default.
W2030437588 abstract "Abstract X-linked lymphoproliferative disease (XLP1) is a rare immunodeficiency characterized by severe immune dysregulation and caused by mutations in the SH2D1A/SAP gene. Clinical manifestations are varied and include hemophagocytic lymphohistiocytosis (HLH), lymphoma and dysgammaglobulinemia, often triggered by Epstein-Barr virus infection. Historical data published before improved treatment regimens shows very poor outcome. We describe a large cohort of 91 genetically defined XLP1 patients collected from centers worldwide and report characteristics and outcome data for 43 patients receiving hematopoietic stem cell transplant (HSCT) and 48 untransplanted patients. The advent of better treatment strategies for HLH and malignancy has greatly reduced mortality for these patients, but HLH still remains the most severe feature of XLP1. Survival after allogeneic HSCT is 81.4% with good immune reconstitution in the large majority of patients and little evidence of posttransplant lymphoproliferative disease. However, survival falls to 50% in patients with HLH as a feature of disease. Untransplanted patients have an overall survival of 62.5% with the majority on immunoglobulin replacement therapy, but the outcome for those untransplanted after HLH is extremely poor (18.8%). HSCT should be undertaken in all patients with HLH, because outcome without transplant is extremely poor. The outcome of HSCT for other manifestations of XLP1 is very good, and if HSCT is not undertaken immediately, patients must be monitored closely for evidence of disease progression." @default.
W2030437588 created "2016-06-24" @default.
W2030437588 creator A5004972535 @default.
W2030437588 creator A5005040866 @default.
W2030437588 creator A5007387587 @default.
W2030437588 creator A5009145909 @default.
W2030437588 creator A5013983797 @default.
W2030437588 creator A5015116246 @default.
W2030437588 creator A5016489221 @default.
W2030437588 creator A5018481010 @default.
W2030437588 creator A5022097331 @default.
W2030437588 creator A5025442855 @default.
W2030437588 creator A5027448862 @default.
W2030437588 creator A5028292912 @default.
W2030437588 creator A5029004287 @default.
W2030437588 creator A5029680324 @default.
W2030437588 creator A5030333997 @default.
W2030437588 creator A5030646889 @default.
W2030437588 creator A5030851924 @default.
W2030437588 creator A5031536047 @default.
W2030437588 creator A5031971166 @default.
W2030437588 creator A5032223113 @default.
W2030437588 creator A5037086699 @default.
W2030437588 creator A5037500529 @default.
W2030437588 creator A5039379107 @default.
W2030437588 creator A5040384200 @default.
W2030437588 creator A5042469434 @default.
W2030437588 creator A5047178566 @default.
W2030437588 creator A5047506862 @default.
W2030437588 creator A5050110768 @default.
W2030437588 creator A5051621566 @default.
W2030437588 creator A5051698298 @default.
W2030437588 creator A5052995460 @default.
W2030437588 creator A5054904756 @default.
W2030437588 creator A5057383623 @default.
W2030437588 creator A5058861543 @default.
W2030437588 creator A5061463272 @default.
W2030437588 creator A5062246565 @default.
W2030437588 creator A5063026687 @default.
W2030437588 creator A5065464020 @default.
W2030437588 creator A5066480716 @default.
W2030437588 creator A5067839858 @default.
W2030437588 creator A5069107002 @default.
W2030437588 creator A5069253954 @default.
W2030437588 creator A5072838648 @default.
W2030437588 creator A5073982969 @default.
W2030437588 creator A5074981701 @default.
W2030437588 creator A5075839647 @default.
W2030437588 creator A5080495909 @default.
W2030437588 creator A5087586201 @default.
W2030437588 date "2011-01-06" @default.
W2030437588 modified "2023-10-03" @default.
W2030437588 title "X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease" @default.
W2030437588 cites W1487843912 @default.
W2030437588 cites W1494681869 @default.
W2030437588 cites W1510178802 @default.
W2030437588 cites W1530742573 @default.
W2030437588 cites W1923455325 @default.
W2030437588 cites W196549467 @default.
W2030437588 cites W1969150464 @default.
W2030437588 cites W1973910785 @default.
W2030437588 cites W1979433816 @default.
W2030437588 cites W1988441535 @default.
W2030437588 cites W1988927480 @default.
W2030437588 cites W2003366154 @default.
W2030437588 cites W2022293841 @default.
W2030437588 cites W2031006767 @default.
W2030437588 cites W2033012336 @default.
W2030437588 cites W2034732921 @default.
W2030437588 cites W2040121223 @default.
W2030437588 cites W2042190865 @default.
W2030437588 cites W2053303000 @default.
W2030437588 cites W2053466113 @default.
W2030437588 cites W2053691244 @default.
W2030437588 cites W2059458791 @default.
W2030437588 cites W2062790922 @default.
W2030437588 cites W2063048567 @default.
W2030437588 cites W2065576711 @default.
W2030437588 cites W2065684619 @default.
W2030437588 cites W2071761673 @default.
W2030437588 cites W2078922411 @default.
W2030437588 cites W2079586845 @default.
W2030437588 cites W2097093285 @default.
W2030437588 cites W2109479983 @default.
W2030437588 cites W2128857896 @default.
W2030437588 cites W2131810356 @default.
W2030437588 cites W2131925046 @default.
W2030437588 cites W2144510654 @default.
W2030437588 cites W2157588893 @default.
W2030437588 cites W2157636290 @default.
W2030437588 cites W2161427499 @default.
W2030437588 cites W2162251899 @default.
W2030437588 cites W23366741 @default.
W2030437588 cites W4252026214 @default.
W2030437588 cites W4254674557 @default.
W2030437588 doi "https://doi.org/10.1182/blood-2010-06-284935" @default.
W2030437588 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3374620" @default.
W2030437588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20926771" @default.